IMPACT BIOMEDICAL INC.

Only the holders of record of our Common Stock at the close of business on the record date, September 8, 2025 (the “Record Date”), are entitled to notice of and to vote at the meeting. On the Record Date, there were 12,185,412 shares of our Common Stock outstanding. Stockholders are entitled to one vote for each share of Common Stock held on the Record Date. DSS BioHealth Securities, Inc., a wholly owned subsidiary of DSS, Inc. owns approximately 83.35% of the voting shares of the Company which includes 60,496,041 shares of the Company’s Series A Convertible Preferred Stock, which is 100% of the Company’s issued and outstanding Series A Convertible Preferred Stock,

Quorum

At all meetings of stockholders of the Company, the presence at the commencement of such meetings in person or by proxy of stockholders holding of record a majority of the voting power of the total number of shares of the Company then issued and outstanding and entitled to vote, shall be necessary and sufficient to constitute a quorum for the transaction of any business. The withdrawal of any stockholder after the commencement of a meeting shall have no effect on the existence of a quorum, after a quorum has been established at such a meeting.